PTG
  • Home
  • Research
    • iBox technology
    • Publications
    • Collaborations
    • Granted Projects
    • Platforms
    • Database access
  • Team
  • News
    • Photo and Video Gallery
  • Job offers
  • PTG in the media
  • About

COVID-19-related medical research: a meta-research and critical appraisal

1/12/2021

 
Picture
As with many fields, science has been put to the test by the coronavirus pandemic. An international team of researchers, led by French scientists, has demonstrated novel scientific practices around Covid-19. Under the pressure of the number of cases and the urgent need to understand the virus, many research groups have shared results, sometimes to the expense of high scientific standards.

During the first wave of the Covid-19 epidemic, medical research saw a historic number of studies on the coronavirus published in a short period of time. An international consortium of experts in medical methodology undertook the major challenge of evaluating the Covid-19 research during this first wave.

Why should the quality of medical research be assessed?

Since the beginnings of medical research, the quality of scientific results has been subject to evaluation using tools and indicators. The aim is to avoid unreliable results and their unfortunate consequences for both research and medical practice. 

​The recent Lancet Gate case is a regrettable example of results discredited following this evaluation. Shortly after the publication of the study in question showing the potential danger of hydroxychloroquine, the World Health Organization recommended that the use of this treatment be stopped. A few days later, the article was discredited, not affecting the WHO's decision. 

French researchers undErtake the mission to evaluate research on Covid-19

In the context of the ongoing Covid-19 pandemic, researchers in many countries have embarked on a global effort to answer pressing questions around coronavirus diagnosis, treatment and prognosis. The urgency has not given way to a systematic evaluation of the quality of studies during the first wave of the epidemic.

"As far as knowledge of the coronavirus is concerned, we are now in an age of reason." Professor Alexandre Loupy, director of a research team in epidemiology, says, "However, given the huge number of publications related to this virus during the first wave, it was natural for us to form this methodology research group, and to evaluate the quality of medical research. »

In order to carry out this ambitious mission, a consortium was formed by Professor Alexandre Loupy, with French, Chinese and American teams. Together, they designed a large-scale study to evaluate the quality of the research of 10,000 studies on Covid-19 during the first wave.

Among the studies reviewed by experts, only 10% of the articles presented original data. The majority of the studies, about 60%, reflected only opinions and contained no new data, which is unprecedented in scientific history. 
The study also shows a diversity of strategies on the communication of scientific results across countries. China was patient and the researchers waited until they had sufficient data to publish. The United States, England and France, on the other hand, did not wait until they had a large number of cases to start publishing a large number of articles, mainly editorials cautiously anticipating the potential evolution of the epidemic. 

"It was a major piece of work," says Marc Raynaud, methodologist and first author of the study, "Although many studies provided valuable data and analysis, other studies were at risk of disseminating unreliable information. Our findings highlight the need to consider medical studies with caution in the context of a pandemic emergency. »

Lessons to be learned from the scientific treatment of the first wave of Covid-19

The authors of the study emphasise that it is essential to converge towards a balance between scientific rigour and velocity. Indeed, some clinical trials have been published with a limited number of patients and little data. The authors believe that their results should be corroborated by additional data. 

​The emergency has also created misunderstandings that have come under the spotlight. Some studies were retracted after receiving a lot of media attention. Social networks may also have played a role in misinformation by relaying potentially biased studies. 

Important note from the authors of the studY

The consortium would like to point out that the research quality of the clinical trials for the Covid-19 vaccine(s) has not been evaluated. Given the period considered by the study, the results of this work cannot therefore be generalised to these clinical trials, which are known to have a strict design and a robust methodology.
Picture
COVID-19-related medical research: a meta-research and critical appraisal

Marc Raynaud, Huanxi Zhang, Kevin Louis, Valentin Goutaudier, Jiali Wang, Quentin Dubourg, Yongcheng Wei, Zeynep Demir, Charlotte Debiais, Olivier Aubert, Yassine Bouatou, Carmen Lefaucheur, Patricia Jabre, Longshan Liu, Changxi Wang, Xavier Jouven, Peter Reese, Jean-Philippe Empana & Alexandre Loupy 
​
BMC Medical Research Methodology volume 21, Article number: 1 (2021) 
Read the paper

Comments are closed.

    Paris Transplant Group

    Our global aim is to accelerate the translation of immunological and gene expression discoveries into the clinical field by filling the gap between basic science and applied biomedical researches.

    CATEGORIES

    Awards
    Events
    Job offers
    Press Releases
    Publications

    See also

    Press coverage
    Video and ​Picture gallery

    ALl

    All
    Alexandre Loupy
    Antoine Bouquegneau
    Antoine Durrbach
    Antoine Roux
    Awards
    Blaise Robin
    Carmen Lefaucheur
    Charlotte Debiais
    Charlotte Loheac
    Christophe Legendre
    Daniel Yoo
    Dany Anglicheau
    Denis Glotz
    Denis Viglietti
    Elodie Bailly
    Events
    Gillian Divard
    Guillaume Bonnet
    Guillaume Coutance
    Huanxi Zhang
    Jean Luc Taupin
    Jean Paul Duong Van Huyen
    Jean Philippe Empana
    Jessy Dagobert
    Job
    Juliette Gueguen
    Kevin Louis
    Marc Raynaud
    Marie-Cécile Bories
    Marion Rabant
    Maud Racape
    Michel Delahousse
    Olivier Aubert
    Pascal Leprince
    Patrick Bruneval
    Peter Reese
    Press Releases
    Publications
    Shaida Varnous
    Valentin Goutaudier
    Xavier Jouven
    Yassine Bouatou
    Zeynep Demir

    Archives

    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    May 2020
    March 2020
    January 2020
    December 2019
    October 2019
    September 2019
    August 2019
    June 2019
    May 2019
    March 2019
    February 2019
    December 2018
    September 2018
    May 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    June 2016
    April 2016
    October 2015
    June 2015
    August 2014
    January 2014
    September 2013
    January 2013
    June 2011
    August 2010
    May 2009

    RSS Feed

Research

iBox technology
PTG Research
PTG Publications
Technical platforms​
Database resources
Covid-related research 🔓

Partnerships

Research collaborations
Technical platforms
​Database access
​

Paris Transplant Group

About PTG
PTG Team
​​Careers at PTG
​
Latest News
Video and Picture Gallery

PTG in the Press
​Contact us

Search

LEGAL NOTICE AND PRIVACY POLICY
© COPYRIGHT 2019. ALL RIGHTS RESERVED.

 LABS EXPLORER for the PARIS TRANSPLANT GROUP.
  • Home
  • Research
    • iBox technology
    • Publications
    • Collaborations
    • Granted Projects
    • Platforms
    • Database access
  • Team
  • News
    • Photo and Video Gallery
  • Job offers
  • PTG in the media
  • About